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Abstract
Gammaherpesvirinae, such as the human Epstein-Barr virus (EBV) and the Kaposi’s sarcoma associated herpesvirus (KSHV)
are highly prevalent pathogens that have been associated with several neoplastic diseases. As EBV and KSHV are host-range
specific and replicate poorly in vitro, animal counterparts such as Murid herpesvirus-4 (MuHV-4) have been widely used as
models. In this study, we used MuHV-4 in order to improve the knowledge about proteins that compose
gammaherpesviruses virions. To this end, MuHV-4 extracellular virions were isolated and structural proteins were identified
using liquid chromatography tandem mass spectrometry-based proteomic approaches. These analyses allowed the
identification of 31 structural proteins encoded by the MuHV-4 genome which were classified as capsid (8), envelope (9),
tegument (13) and unclassified (1) structural proteins. In addition, we estimated the relative abundance of the identified
proteins in MuHV-4 virions by using exponentially modified protein abundance index analyses. In parallel, several host
proteins were found in purified MuHV-4 virions including Annexin A2. Although Annexin A2 has previously been detected in
different virions from various families, its role in the virion remains controversial. Interestingly, despite its relatively high
abundance in virions, Annexin A2 was not essential for the growth of MuHV-4 in vitro. Altogether, these results extend
previous work aimed at determining the composition of gammaherpesvirus virions and provide novel insights for
understanding MuHV-4 biology.
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Introduction
The Herpesviridae is a large family of DNA viruses, including
eight identified human herpesviruses. The gammaherpevirinae is one
of the three subfamilies of the Herpesviridae. Two gammaherpes-
viruses are known to infect humans, Epstein-Barr virus (EBV) and
the Kaposi’s sarcoma-associated herpesvirus (KSHV), which are
associated with various types of cancer such as Burkitt’s
lymphoma, nasopharyngeal carcinoma, Kaposi’s sarcoma or
Castleman’s disease [1,2]. Both EBV and KSHV have a very
narrow host range in vivo and display limited lytic growth in vitro.
These characteristics have hampered studies on these viruses and
promoted the development of alternative models.
Murid Herpesvirus 4 (MuHV-4) is a relative of EBV and KSHV
which has been isolated in wild rodents [3]. MuHV-4 offered
therefore the possibility of developing a mouse model of
gammaherpesvirus pathogenesis [3–5]. Moreover, in contrast to
its human counterparts, MuHV-4 readily infects many types of
cells in vitro and replicates to high levels. This virus has therefore
been widely used as a model to study the gammaherpesviruses
biology in host cells [6].
The MuHV-4 genome is estimated to encode at least 80 genes
and is largely colinear with those of KSHV and EBV [7]. MuHV-
4 virions display a morphological organisation which is typical of
herpesviruses [8]. Briefly, infectious virions contain a double-
stranded DNA genome which is incorporated in a large (diameter
.100 nm) icosahedral nucleocapsid. This capsid is assembled in
the nucleus from at least 8 different conserved proteins [9] and is
surrounded by a thick proteinaceous tegument compartment
which is acquired in both the nucleus and the cytoplasm. The
tegument is probably the least understood part of herpesviruses
although it plays important roles during entry, virion assembly and
egress [10–12]. Recent studies have attempted to decipher its
complex architecture [13]. The cytoplasmic capsids with tegument
are finally enclosed within a lipid bilayer envelope spiked with
glycoproteins to form mature infectious virus particles (diameter
,200 nm). MuHV-4 encodes at least 9 envelope glycoproteins
involved in virion entry and egress from the cell [14–21]. Among
these glycoproteins, gB, gH, gL, gM and gN are shared by all the
members of the Herpesviridae family [22].
In addition to virally encoded structural proteins, several
cellular host proteins have also been reported in herpesvirus
virions. While some of these proteins appear to be unique to a
PLOS ONE | www.plosone.org 1 December 2013 | Volume 8 | Issue 12 | e83842
virus species, others are shared by several members of the
Herpesviridae family. Although some cellular proteins incorporated
in virions have been shown to be important for the biology of
viruses from other families [23], the function of these proteins is
still largely unknown in herpesviruses. A precise knowledge of
herpesvirus composition is therefore likely to allow better
understanding of various processes such as virus production,
virion entry or immune evasion.
The usage of mass spectrometry-based analyses (MS) has
allowed the deciphering of the composition of different herpesvirus
virions [24–36]. Such an approach has been applied more than
ten years ago to MuHV-4 virions [26]. However, this pioneering
work revealed only 14 structural viral proteins whereas herpesvirus
virions likely contain more than 30 different proteins [36].
Moreover, this study identified products of genes ORF20,
ORF24 and ORF29 as virion proteins although their homologues
were not found in most of the analyses of virions of related species.
For example, ORF29 encodes a component of the viral terminase
which is thought to dissociate from the capsid after genome
packaging and therefore to not be incorporated in mature
extracellular virions [31]. The composition of extracellular mature
MuHV-4 virions deserves therefore new analyses.
In this study, 31 structural MuHV-4 proteins were identified by
a recently described mass-spectrometry-based proteomic ap-
proach. In parallel, a small number of host proteins were also
detected although their significance remains unclear. Altogether,
these results extend our knowledge about gammaherpesvirus




Baby Hamster Kidney cells (BHK-21 (ATCC CCL-10)) were
cultured in Dulbecco’s modified Eagle’s medium (Invitrogen)
containing 10% foetal calf serum (FCS), 2% Penicillin/Strepto-
mycin (Invitrogen), 2 mM glutamine and 1% non-essential amino
acids (Invitrogen). Mouse embryonic fibroblasts (MEF) from wild-
type (WT) and Annexin A2-null mice [37] were kindly provided
by Prof. Katherine A. Hajjar (Weill Cornell Medical College, New
York, NY, United States) and were cultured in the same culture
medium containing 1mM sodium pyruvate. Virions of the MHV-
68 strain of MuHV-4 reconstituted from the pHA3 BAC plasmid
[38] were used throughout this study. This viral strain therefore
expresses eGFP under control of the immediate early promoter of
human cytomegalovirus.
Production and Purification of MuHV-4 Virions
BHK-21 cells were infected with MHV-68 at a multiplicity of
infection (MOI) of 0.01 plaque-forming unit (PFU) per cell. To
reduce cellular contaminants, the supernatant was harvested after
72 hours post-infection (hpi) before complete cell lysis. Extracel-
lular virions were purified from the cell supernatant as described
previously [36]. Briefly, after removal of the cell debris by low-
speed centrifugation (1,000 g, 10 min at 4uC), virions present in
the infected cell supernatant (,1–56106 PFU/mL) were harvest-
ed by ultracentrifugation (100,000 g, 2 h at 4uC) through a 30%
weight/volume (w/v) sucrose cushion. Virions were then banded by
isopycnic gradient ultracentrifugation in a continuous 20 to 50%
(w/v) potassium tartrate gradient in PBS (100,000 g, 2 h at 4uC).
The band containing virions was collected (,3 mL), diluted ten
fold in PBS and pelleted by ultracentrifugation (100,000 g, 2 h at
4uC). The virion pellet was finally resuspended in PBS and virus
enriched preparations (,1–56108 PFU/mL) were stored at
280uC.
Protease Treatment
Virions were treated with proteinase K as described previously
[30]. Briefly, after ultracentrifugation through the sucrose cushion
described above, the viral pellet was resuspended in 1 ml of MNT
buffer (30 mM morpholineethanesulfonic acid [MES], 10 mM
NaCl, and 20 mM Tris-HCl [pH 7.4]) containing 10 mg/ml
proteinase K (Roche, Mannheim, Germany), incubated for
45 min at room temperature and subsequently treated with
2 mM phenylmethylsulfonyl fluoride (PMSF; Fluka) prior to
density gradient centrifugation on a 20 to 50% (w/v) potassium
tartrate gradient in PBS (100,000 g, 2 h at 4uC). The band
containing virions was collected (,3 mL), diluted ten fold in PBS
and pelleted by ultracentrifugation (100,000 g, 2 h at 4uC).
Proteinase K-treated virions were finally resuspended in PBS
and stored at 280uC.
Western Blotting
Purified virions were lysed and denatured by heating (95uC,
5 min) in Laemmli sample buffer (60 mM Tris-Cl pH 6.8, 2% (w/
v) sodium dodecyl sulfate, 12.5% (w/v) glycerol, 5% (v/v) b-
mercaptoethanol, 0.01% (w/v) bromophenol blue). Proteins were
resolved by electrophoresis on Mini-PROTEAN TGX (Tris-
Glycine eXtended) precast 4–15% resolving gels (Bio-Rad) in an
SDS-PAGE running buffer (25mM Tris-base, 192 mM glycine,
0.1% (w/v) SDS) and transferred to polyvinylidene difluoride
membranes (Immobilon-P transfer membrane, 0.45 mM pore size,
Millipore). The membranes were blocked with 3% (w/v) non-fat
milk in PBS/0.1% (w/v) Tween-20, and then incubated in the
same buffer with rabbit polyserum [5] or mouse monoclonal
antibodies (mAb) recognizing MuHV-4. We used the following
mAbs: 3F7, anti-gN IgG2a [39]; T1A1, anti-gp150 IgG2a [40]; 58-
16D2, anti-gp70 IgG2a [15]; MG-4D11, anti-gB IgG2a; MG-
2C10, anti-gB IgM [41]. Bound antibodies were detected with
horseradish peroxidase-conjugated goat anti-rabbit IgG pAb or
anti-mouse IgG pAb (Dako Corporation), followed by washing in
PBS/0.1% Tween-20, development with ECL substrate (GE-
Healthcare) and exposure to X-ray film.
Fractionation of MuHV-4 Virions
Lipid envelopes were removed from capsids-teguments by
incubation with a non-ionic detergent as described previously [42].
Briefly, virions enriched preparations were sonicated and lysed in
PBS containing 1% (v/v) NP-40 for 20 min on ice. Capsids
associated with tegument were then pelleted by centrifugation
(15,000 g, 30 min at 4uC). The supernatant was discarded and the
procedure was repeated two times on the capsid-tegument pellet.
After the last centrifugation, the capsid-tegument pellet was finally
resuspended in PBS and stored at 280uC until further use.
Negative Staining and Electron Microscopy
Copper grids (400 mesh; Agar Scientific) covered by a thin film
of pioloform were incubated for 10 min with 1% Alcian blue 8G
solution (Gurr Microscopy Materials, BHD) to add positive
charges. After washing, virion-enriched or capsid-tegument
preparations were adsorbed to the grids for 10 min. Viral particles
were then stained by incubation on a 2% uranyl acetate solution
for 10 s (Agar Scientific). Samples were observed using a
transmission electron microscope (FEI Tecnai Spirit).
MuHV-4 Structural Proteome
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Oligosaccharide Digestion
The deglycosylated extract was obtained by treating virion-
enriched preparations with an Enzymatic Protein Deglycosylation
kit (Sigma) following the instructions of the manufacturer. Viral
proteins were successively denatured for 5 min at 100uC in a
denaturation solution, and treated with Triton X-100, peptide :N-
glycosidase F, O-glycosidase, a(2–3,6,8,9)neuraminidase, b(1,4)-
galactosidase and b-N-acetylglucosaminidase for 3 h at 37 uC.
This extract was then submitted to the one dimensional gel
electrophoresis/Nanoscale liquid chromatography coupled to
tandem mass spectrometry approach (1D gel/nanoLC-MS/MS
approach).
1D gel/nanoLC-MS/MS Approach
Proteins from virion-enriched (treated or not with proteinase K,
deglycosylated or not) and from capsid-tegument preparations
were extracted in Laemmli sample buffer and heated for 5 min at
95uC. The samples were then separated by SDS-PAGE on 4–20%
acrylamide 7 cm gels (Invitrogen). Separated proteins in the gel
were excised in 30 serial slices along the lane. Gel slices were
submitted to in-gel digestion with sequencing grade modified
trypsin as described previously [33,36]. Briefly, gels were washed
successively with 50 mM ammonium bicarbonate (ABC) buffer
and ABC buffer/acetonitrile (ACN) 50% (v/v). Proteins were
reduced and alkylated using dithiothreitol and iodoacetamide
followed by washing with ABC and ABC/ACN. Resulting
peptides were analysed by nanoLC-MS/MS using a 40 min
ACN gradient as described [43].
MS/MS Analyses
Peptides were analysed using the ‘peptide scan’ option of the
HCT Ultra ion trap (Bruker), consisting of a full-scan MS and
MS/MS scan spectrum acquisitions in ultrascan mode (26 000 m/
z s21). Peptide fragment mass spectra were acquired in data-
dependent AutoMS(2) mode with a scan range of 100–2800 m/z,
three means and four precursor ions selected from the MS scan
300–1500 m/z. Precursors were actively excluded within a
0.5 min window, and all singly charged ions were excluded.
Peptide peaks were detected and deconvoluted automatically using
Mascot distiller 2.3.3 and submitted to database search using an
in-house mascot search engine (2.2 version). The default search
parameters used were the following: Enzyme=Trypsin; Maxi-
mum missed cleavages = 2; Fixed modifications =Carbamido-
methyl (C); Variable modifications =Oxidation (M); Peptide
tolerance 61.5 Dalton (Da); MS/MS tolerance 60.5 Da; Peptide
charge = 2+ and 3+; Instrument =ESI-TRAP. All data were
searched against the NCBI Rodents database in order to detect
host proteins or against a MuHV-4 database [44] to detect viral
proteins. Proteins were only considered if reaching a p-value for
identification lower than 0.05. Only peptides with a mascot score
higher than 30 were taken into account. Identifications based on
single peptide were validated manually considering that a
continuous series of at least 5 b or y ions had to be present and
that selected ions had to be among the top 15 ions of the spectrum.
For each approach, the exponentially modified protein abundance
index (emPAI) [45] was calculated to estimate protein relative
abundance for the complete virion extracts. The protein
abundance index (PAI) is defined as the number of observed
peptides divided by the number of observable peptides per protein.
The exponentially modified PAI (10PAI - 1) is proportional to
protein content in a protein mixture in LC-MS/MS experiments.
Proteogenomic Mapping
The complete nucleotide sequence of MuHV-4 (GenBank:
AF105037.1) was translated in silico in all 6 frames. The mass lists
obtained in the different complete virion analyses were searched
against these 6 frames with no mismatches allowed. Detected
peptides were then mapped onto the original MuHV-4 genome
sequence (GenBank: AF105037.1 and [7]). The results were
generated and visualized using R [46] and the seqinr package [47].
Growth Curves
Cell cultures were infected with MuHV-4 virions at a MOI of
0.01 (multi-step assay). After 1 h of adsorption, the cells were
washed then overlaid with Dulbecco’s modified Eagle’s medium
containing 5% FCS. Supernatants of infected cultures or infected
cells were harvested at successive intervals and the amount of
infectious virus determined by plaque assay on BHK-21 cells.
Results
Purification of Extracellular MuHV-4 Virions
The purification of extracellular mature virions is very
important for the characterization of viral structural proteomes.
Indeed, it has to be very pure to avoid detection of non-structural
proteins but in the same time to be highly concentrated. In the
present study, we used a strategy recently used for the
characterization of BoHV-4 virions [36]. Briefly, MuHV-4
extracellular virions were harvested and purified from the
supernatant of BHK-21 infected cells before complete lysis as
described in the Materials and Methods. Transmission electron
microscopic (TEM) analysis of negatively stained samples was used
to evaluate both the concentration and the purity of all the
preparations (Fig. 1). In all samples, typical herpesvirus virions
were observed. These appear as spherical to slightly pleomorphic,
relatively electron-lucent features of 120–200 nm in diameter.
These virions with an intact envelope displayed no specific internal
and surface features in negative staining. Because of the drying
during the negative staining, some of the virions collapsed such
that the envelope was penetrated by the stain (Fig. 1, panel ii). In
that case, the nucleocapsids were observable, surrounded by the
integument and the envelope. Only a few nucleocapsids without
envelope were found (1 to 5% in the different samples). Most
likely, these had no envelope or lost their envelope during virus
purification. We did not observe any contamination by cell debris,
suggesting that the virion samples were very pure. This therefore
indicates that our virion purification strategy could be considered
as successful, at least as evaluated by TEM.
Viral Protein Composition of MuHV-4 Virions
In order to analyse MuHV-4 virion composition, virion proteins
were separated by SDS-PAGE, digested in gel with trypsin and
analysed by mass spectrometry (nanoLC-MS/MS). This approach
allows association of the identified protein with the apparent
molecular mass assessed by SDS-PAGE. This approach was
performed on untreated virions or on intact virions treated with
proteinase K (proteinase K - 1D gel/nanoLC-MS/MS). We also
applied the same protocol on deglycosylated virion extracts.
This approach enabled us to identify 31 virally encoded proteins
in the MuHV-4 particle. These proteins are listed in Table 1
according to their position in the viral genome. This number is
consistent with the numbers previously reported for other
members of the Herpesviridae family. Moreover, it substantially
improved a previous analysis of MuHV-4 virions that identified 14
virally encoded structural proteins [26].
MuHV-4 Structural Proteome
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Despite our multistep purification protocol, detection of some
proteins could result from non-specific sticking to the virion rather
than true integration into the particle. To address this issue, we
treated virions with proteinase K, in the absence of detergent,
prior to density centrifugation as described previously [30,32,36].
We validated this treatment by western blotting (Fig. 2). As
herpesviruses are enveloped within a phospholipid bilayer, only
proteins that are exposed at the viral surface are accessible to
protease digestion. Immunoblotting with MuHV-4 specific mono-
clonal antibodies confirmed that some epitopes disappeared after
proteinase K treatment while some others were not affected
(Fig. 2). Thus, the epitope recognized by mAb T1A1 (recognizing
gp150) was detected only in untreated virions while it was
undetectable in proteinase-K treated virions (Fig. 2). This
therefore suggests that our proteinase K treatment was efficacious.
In contrast, the viral surface epitope recognized by mAb 3F7
raised against gN, which is a small (61 aa among which only 29 aa
are exposed at the cell surface) type I membrane protein lying
probably very close to the envelope, did not appear to be affected
by the treatment (Fig. 2).
Among the 31 proteins described in Table 1, only pORF55 was
not detected in the proteinase K - treated sample. Analysis of the
peptide sequence coverage of viral proteins identified by mass
spectrometry revealed that, although some MuHV-4 envelope
glycoprotein epitopes were sensitive to proteinase K digestion
(Fig. 2), proteinase K treatment did not affect the detection of most
of the viral proteins even those that are exposed at the surface of
the virion. Thus, the peptide sequence coverage of gB, which is the
envelope protein detected by the bigger number of unique
peptides (Table 1), was 51.8% and 53% respectively in untreated
and proteinase K-treated virions. Finally, no additional protein
was specifically detected after proteinase K treatment.
Estimation of Protein Abundance in MuHV-4 Virion
We previously used the emPAI value (exponentially modified
protein abundance index) developed by Ishihama et al. to estimate
the protein contents in our samples [36,45,48]. In order to
relatively quantify viral proteins in virions, emPAI values were
expressed as percentages of the emPAI value obtained for
pORF25, the major capsid protein (Table 1). Based on these
relative emPAI values, the tegument protein encoded by ORF52
was, by far, the most abundant protein detected in MuHV-4
virions. It was more than 20 times more abundant than pORF25.
This apparent abundance could not be biased through the
enhanced detection of a single peptide as 12 different pORF52
peptides were detected in similar proportions by our analyses
(Table 1).
Figure 1. Assessment of MuHV-4 virion purity. The purity of the virions (i and ii) and capsid-tegument fractions (iii and iv) preparations was
assessed by negative staining and electron microscopy. Scale bars are shown on the images.
doi:10.1371/journal.pone.0083842.g001
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Identification of Viral Capsid and Capsid Associated
Tegument Components
In order to identify capsid proteins and tegument proteins
associated with capsids, we purified viral capsid-tegument fractions
as described in the Materials and Methods. We estimated the
purity and concentration of the purified capsid-tegument prepa-
ration by TEM (Fig. 1, panels iii and iv). As expected, the sample
contained only isolated capsids and no trace of intact virions or
envelope debris.
The 1D gel/nanoLC-MS/MS approach revealed the presence
of 18 viral proteins in this sample (Table 2). As expected, no
predicted viral envelope glycoprotein (encoded by ORF4, ORF8,
ORF22, ORF27, ORF28, ORF39, ORF47, ORF51 and ORF58)
was detected in this sample confirming the quality of our
purification procedure. Moreover, proteins encoded by M3,
ORF38, ORF45 and ORF55 were also not detected in this
sample although they had been detected in complete virions. For
ORF38, ORF45 and ORF55, the absence of detection could be
associated with their low abundance as very few peptides derived
from these proteins were detected in intact virions. The absence of
detection could also reflect the fact that they are not directly
associated with capsids. In this case they could be considered as
outer tegument proteins. Regarding M3, as it is a secreted protein,
its absence from tegument was expected.
As performed above for entire virions, the relative protein
abundances were estimated by emPAI values. These values were
expressed as percentages of the emPAI value obtained for
pORF25, the major capsid protein (Table 2). As observed for
intact virions, the tegument protein encoded by ORF52 was by far
the most abundant protein detected in this preparation.
Proteogenomic Mapping
Our identification of MuHV-4 structural proteins by mass
spectrometry is based on the ORFs annotations of the MuHV-4
genome. In order to identify possible MuHV-4 virions proteins
that had not been annotated, we generated a database containing
the entire genome of MuHV-4 translated in the 6 frames. The
mass lists obtained in the different complete virions analyses were
searched against this database as described in the Materials and
Methods. Finally, the detected peptides were graphically mapped
onto the MuHV-4 genome (Fig. 3). The results obtained showed
that all peptides identified by our analyses mapped into previously
annotated ORFs.
This approach allowed us to easily analyse the localization of
detected peptides within protein sequences. This was particularly
useful for the ORF17–17.5 proteins (Fig. 3 and S1). Rhadino-
viruses ORF17.5 encode the homolog of HSV-1 VP22a which
serves as a scaffold protein during capsid maturation and is
therefore mainly found in procapsids and B capsids [9]. As
observed in other herpesviruses, the coding sequence of this
protein is entirely contained within and in frame with a larger
open reading frame, called ORF17 in rhadinoviruses. This larger
open reading frame encodes a protease (homologous to HSV-1
VP24) involved in capsid maturation by degrading scaffold
proteins. Interestingly, analysis of the ORF17–17.5 peptides
distribution showed that these peptides were located into the
ORF17 specific N-terminal region. These results suggest therefore
that the pORF17 protease was the major ORF17-17.5 product
present in our virion preparation. However, it has to be noted that
some ORF17.5 peptides were found in the capsid-tegument
preparation, some trace of the scaffold protein were therefore
detected.
Glycosylation of Virion Components
In order to improve the sensitivity of our approach, we
performed the 1D gel/nanoLC-MS/MS analysis on deglycosy-
lated virion proteins as described in the Materials and Methods.
We validated this treatment by western blotting (Fig. S2). The
apparent molecular mass of glycoprotein gp70 and of the C- and
N-terminal parts of gB appeared to be reduced while the total
protein content revealed by an anti-MuHV-4 polyserum did not
appear to be affected (Fig. S2). However, compared to the analysis
of intact virions, we were not able to detect any new viral
structural protein (Table 1). In contrast, peptides corresponding to
proteins encoded by M3, ORF17, ORF45 and ORF55 were not
detected in the deglycosylated sample.
The comparison of results obtained by the 1D gel/nanoLC-
MS/MS approaches performed on untreated and deglycosylated
samples run in parallel allowed us to predict glycosylation of
several virion proteins. We limited our analysis on detected
envelope proteins as most of them are predicted to be N- and/or
O-glycosylated (Fig. S3). Briefly, both samples were submitted to
1D gel electrophoresis as described in the Materials and Methods.
After protein migration, the gels were cut in 30 slices and protein
composition of each of the 30 slices was determined as described.
Distribution across the gel was then determined for each protein
and compared between deglycosylated or untreated sample.
In comparison with their theoretical mass (calculated from
amino acid composition), all the proteins, excepted gL, displayed a
higher apparent molecular mass, suggesting important posttrans-
lational modifications (Fig. 4). We considered that there were
differences of glycosylation when detection profiles differed by
more than one positive box. In the case of the proteins encoded by
ORF4 (gp70), ORF8 (gB), ORF22 (gH), ORF27 (gp48), ORF47
(gL) and ORF58, the deglycosylation procedure induced a
decrease of the apparent molecular mass, suggesting that these
proteins are glycosylated. It should be noted that MuHV-4 gB has
a theoretical molecular mass (MM) of ,96 kDa. However,
MuHV-4 gB has a furin consensus cleavage sequence at amino
acids 424 to 427 (RRKR) [49]. It has been shown experimentally
Figure 2. Sensitivity of viral proteins to proteinase K treatment
of virions. Western blotting analysis of viral proteins in purified virions
from mock (–) and proteinase K (+) treated samples. Gp150 and gN are
type I transmembrane proteins which have a N-terminal domain
predicted to be sensitive to proteinase K digestion.
doi:10.1371/journal.pone.0083842.g002
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that the cleavage is indispensable for virion incorporation and
results in two derived products of respectively 55 and 65 kDa [49].
Although N- and/or O-glycosylation had previously been
shown for pORF28 and pORF51 (gp150), our experimental
procedure did not allow us to detect it. In the case of pORF51
(gp150), this is probably associated with an aberrant migration of
the protein. This could be due to the high proline content (23%) of
the protein, which is known to increase the apparent molecular
mass on SDS-PAGE gels [50]. pORF39 (gM) and pORF58 also
migrate to aberrant positions. This could be associated with the
multiple transmembrane domains of these proteins [14,39]. This
could also reflect the formation of protein aggregates due to the
conditions used in SDS-PAGE preparation as it has previously
been shown for KSHV gM [51].
Although peptides corresponding to pM3 had been observed in
all the replicate analyses that were performed on intact virions, no
M3-derived peptides were detected in the deglycosylated sample
(Table 1 and Fig. 4).
Host Proteins Associated with MuHV-4 Extracellular
Virions
Several host proteins have been detected in mature herpesvirus
virions. We therefore also searched for proteins of non-viral origin
in the 1D gel/nanoLC-MS/MS analyses performed on intact
virions. In total, we identified 31 cellular proteins that were
detected in at least two of the three replicates (Table 3). Among
these proteins, only 11 proteins were still detected after proteinase
K-treatment (Table 3). Manual categorization of the identified
proteins according to their previously known molecular function
was performed as described for analyses of BoHV-4 [52] and PRV
virions [30]. As for these viruses, many proteins involved in
cellular signalling, cytoskeleton organization and membrane
organization and trafficking were found (Table 3).
We have chosen to investigate more in depth the role of
Annexin A2 in the MuHV-4 cycle for the following reasons: (i) the
estimation of protein abundance by emPAI revealed that Annexin
A2 is one of the more abundant host proteins detected in MuHV-4
virions; (ii) among the host proteins that were still detected after
proteinase K treatment, only Annexin A2 had previously been
associated with MuHV-4 virions [26]; (iii) finally, Annexin A2 is
the protein that is the most frequently associated with herpesvirus
virions (Table 3). Based on these observations, it was therefore
plausible that Annexin A2 plays a role in MuHV-4 biology.
Interestingly, mouse deficient for Annexin A2 have been generated
previously [37]. This was therefore a unique opportunity to
investigate more in depth the role of this protein in the MuHV-4
cycle.
Figure 3. Proteogenomic map of MuHV-4 structural peptides. The 6 possible frames of the MuHV-4 genome (AF105037.1) translation are
shown with rectangle indicating annotated ORFs. Red and blue ORFs represent forward and reverse frames respectively. Detected peptides are
shown by bars whose the height is proportional to the number of detections. Genomic positions in bp are indicated.
doi:10.1371/journal.pone.0083842.g003
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To address this question, we compared the growth of WT
MuHV-4 virus on WT or Annexin A2 deficient MEF cells. The
results obtained showed that MuHV-4 grew to similar titers in WT
and Annexin A2 deficient-MEF cells (Fig. 5). Finally, as Annexin
A2 has been proposed to play a role in the entry of different viruses
including herpesviruses, we examined MuHV-4 entry into WT
and Annexin A2 deficient MEF cells. Briefly, we incubated WT or
Annexin A2 deficient MEF cells with a BoHV-4 WT strain
expressing eGFP (0.4 PFU/cell) for various times before washing
the cells with PBS or with an acidic solution (PBS pH3). The cells
were then incubated in complete medium and the numbers of
infected cells (eGFP+) were then determined by flow cytometry
18 h later. We did not observe any difference in MuHV-4 entry
between the two cell types (data not shown).
Discussion
The composition of herpesvirus virions has already been
addressed by several studies. However the diversity of the
purification and mass spectrometry procedures used has led to
variable results. While analyses of Herpes-Simplex (HSV-1) and
Pseudorabies (PRV) virions identified respectively 44 and 47 viral
structural proteins [30,31], analyses of rhadinoviruses gave much
more variable results. Thus, 37, 33, 25 and 14 viral structural
proteins were revealed in BoHV-4 [36], Rhesus rhadinovirus
(RRV) [32], KSHV [25,34] and MuHV-4 [26] extracellular
virions respectively. Moreover, only 10 proteins were common
between the different analyses. As mass spectrometry approaches
are continuously evolving, we have reassessed the composition of
MuHV-4 virions. Our analyses allowed the identification of 31
structural proteins encoded by the MuHV-4 genome which were
classified as capsid (8), envelope (9), tegument (13) and unclassified
(1) structural proteins. Among these 31 proteins, 27 were also
found in at least three of the four rhadinovirus virions
characterized to date (BoHV-4, KSHV and RRV) (Table S1).
Capsid Proteins
Despite considerable sequence divergence, the structure and
arrangement of the capsid proteins is remarkably conserved across
Herpesviridae [9,53]. Herpesviruses have a T16 icosahedral capsid.
The main component of the capsid is the major capsid protein
(MCP), encoded by ORF25 in rhadinoviruses. MCP makes up
both capsomere structures, the pentons (n = 11) and hexons
(n = 150), which contain five and six MCP monomers, respective-
ly. In the capsid, the hexons form the faces and edges while
pentons are located at 11 of the vertices of the icosahedron. The
last vertice is unique and consists of 12 copies of a portal protein
(ORF43 in rhadinoviruses). These portal proteins are arranged as
a ring through which viral DNA is encapsidated. The pentons and
hexons are bridged together by 320 triplexes which are composed,
in rhadinoviruses, of two copies of pORF26 and one copy of
pORF62. The capsid is firstly assembled (procapsid) around a
morphogenic scaffolding core made of pORF17.5 which under-
goes proteolysis by pORF17 during maturation. Finally, a small
basic capsid protein (pORF65) is added only after procapsid
maturation. Two additional minor capsid proteins, pORF19 and
pORF32, associate with capsid triplexes and form the capsid
vertex-specific complex (CVSC) which is necessary for viral DNA
cleavage and packaging. In this study, we identified all of these
proteins (Tables 1 and 2). Analysis of the protein abundances
(based on emPAI) conformed to the theoretical values excepted for
pORF43, pORF62 and pORF65 which were more abundant than
expected. We do not have any explanation for this high relative
abundance compared to the other capsid proteins. However,
ORF65 encodes the small capsid protein of rhadinoviruses which
decorates the hexon configuration of the major capsid protein. On
the basis of full occupancy, it should be a very abundant capsid
Figure 4. Analysis of MuHV-4 structural protein glycosylation. Control or deglycosylated proteins of purified MuHV-4 virions were separated
by SDS-PAGE. After migration, each sample was divided in 30 serial slices along the lane and proteins of each slice were identified as described in the
Materials and Methods. For the two treatments, slices containing M3, ORF4 (gp70), ORF8 (gB), ORF22 (gH), ORF27 (gp48), ORF28, ORF39 (gM), ORF47
(gL), ORF51 (gp150) and ORF58 proteins are shown with color intensity indicating the mean relative abundance (emPAI). For each lane, the
abundances are expressed relatively to the band displaying the highest emPAI which is taken as 1. For each protein, predicted molecular mass is
shown (theoretical lane). For the gB protein, the dashed slice indicated the predicted position of gB proteins before potential cleavage by cellular
furin. The position of a MM standard is shown on the left.
doi:10.1371/journal.pone.0083842.g004
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Table 3. Cellular proteins detected in MuHV-4 virions and comparison to other herpesviruses.
Relative
eMPAI
(%)a pKc Gammaherpesvirinae Alphaherpesvirinae Beta-b
Rhadinoviruses Maca- b Lymph- b Simpl-b Varicel- b Cyto- b
Protein description Acc. N6 KSHV d BoHV-4 d AlHV-1 d EBV d HSV-1 d PRV d HCMV d
Small GTPases
Rab-1A isoform 1 gi|4758988 9.7 - +
Rab-6A isoform 2 gi|13195674 10.3 + + +
Rab GDP diss.inhib.beta-like gi|354465044 0.9 + +
Immunity-ass.nucleotide 4 gi|13569476 1.2 -
Vesicle transport protein gi|344256341 2.0 -
ADP-ribosylation factor 2 gi|6671571 8.7 - +
Ras-related protein Rab-14 gi|16758368 4.3 + +
Signalling
Casein kinase II subunit beta gi|7106277 3.1 - + + +
Annexin A3 gi|344255510 1.3 +
CD 81 antigen gi|194135609 10.5 -
S/T-protein Pase PP1-alpha gi|4506003 5.3 + + +
Thy-1 membrane glycoprotein gi|344240805 3.0 - +
Cytoskeleton
Cofilin-2 gi|6671746 3.6 - + +
Microtubule-ass prot.RP gi|7106301 3.1 -
Protein 88B gi|109463441 0.4 -
Moesin gi|344240889 1.4 - + +
Tetraspanin gi|685221 1.8 -
DNA binding
Histone H2A type 1 gi|344240017 14.9 +
Histone H4 gi|344240018 3.7 - +
Membrane organization and trafficking
VAMP 3 gi|6678553 12.3 + +
Annexin A2e gi|6996913 8.3 + + + + + + +
Annexin 1 gi|235879 2.0 - + + + + +
Metabolism
GAPDH gi|56188 2.2 + + + + +
F1-ATPase beta subunit gi|203033 1.3 -
Ion channel
VDAC-1 gi|344238883 2.8 -
Cell adhesion
Protein CLEC16A-like gi|348584902 0.4 -
Protein folding and protease
PPIase A gi|351706205 13.0 +
Anionic trypsin-1 precursor gi|6981420 4.3 +
Polyubiquitin gi|1050930 4.7 - +
GroEL_like type I chaperonin gi|51452 0.8 -
Immunity
C4BP gi|354471099 0.6 -
aRelative eMPAI values were calculated as the eMPAI values calculated for each analysis relatively to the abundance of pORF25 taken as 100%.
bBeta-, Beta-herpesvirinae; Maca-, Macaviruses; Lymph-, lymphocryptoviruses; Simpl-, simplexviruses; Varicel-, varicelloviruses; Cyto-, cytomegaloviruses.
cpK: Proteinase K treatment. +, proteins detected in the Proteinase K - 1D gel/nanoLC-MS/MS.
dBased on previously published studies.
eProteins previously identified in MuHV-4 virions [26] are highlighted in bold.
doi:10.1371/journal.pone.0083842.t003
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protein. Our results are therefore in accordance with this
hypothesis. In contrast, we had shown that pORF65 was not
abundant in BoHV-4 virion [36]. This could reveal different roles
of this protein in these two species. Interestingly, pORF65
homologues are non-essential in alpha- and beta-herpesvirinae, but
KSHV pORF65 is required for capsid formation [54]. The roles
of pORF65 in BoHV-4 and MuHV-4 could therefore be different
and will require further investigation.
Similarly to what we observed with BoHV-4, none of the viral
terminase components, pORF7, pORF29 and pORF67.5, were
detected in our analysis of mature MuHV-4 virions in contrast
with KSHV and human cytomegalovirus (HCMV) and with the
previous analysis on MuHV-4 virions (Table S2) [26,34,35]. This
result reinforces therefore the model in which the herpesvirus
terminase complexes dissociate from the C-capsid after genome
encapsidation. Moreover, the absence of the terminase complex,
the high levels of pORF65 and the very low levels of pORF17.5
(homologous to HSV-1 VP22a) (Fig. S1) suggest that our virus
preparations contained mostly mature extracellular virions.
Tegument Proteins
In contrast to the capsid, herpesvirus tegument remains largely
undefined. The first step toward the understanding of its
organization is therefore the identification of all of its components.
Our analysis identified 13 potential viral tegument proteins
associated with MuHV-4 virions (proteins encoded by ORFs 11,
21, 23, 33, 36, 38, 45, 52, 55, 63, 64, 75c and 75b). Among these
proteins, proteins encoded by ORFs 11, 21, 33, 45, 52, 63, 64 and
75c have all been detected in KSHV tegument [25,34,55] while
proteins encoded by ORFs 23, 36, 38, 55 and 75b were not.
Although being conserved among gammaherpesviruses, the
function of ORF23 is unknown and a recent study of MuHV-4
showed that pORF23 was not essential for in vitro or in vivo growth
[56]. Its presence in the MuHV-4 virion is possible based on its
similarity with the tegument protein pUL21 of alphaherpesviruses
which is involved in egress of capsids from the nucleus [57].
ORF36 encodes a conserved gammaherpesvirus protein kinase
[58,59] which has also been detected in BoHV-4 [36] and RRV
[32]. Proteins encoded by ORF38 and ORF55 are fatty acylated
proteins conserved throughout the herpesvirus family. They have
been detected in the tegument of many herpesviruses and are
involved in virion envelopment and/or egress [60,61]. Finally,
pORF75b has been described as a virion component [62]. All
these proteins, except pORF55, were detected after proteinase K
treatment of virions (Table 1) and should therefore be considered
as real tegument components. pORF55 was only detected by two
peptides and its absence in proteinase K treated virions likely
reflects its low abundance in viral particles.
In contrast to these proteins, our analyses did not detect proteins
encoded by ORFs 6, 20, 35, 42, 48, 50, 67 and 75a which had
previously been described as potential tegument proteins in KSHV
[55]. In particular, pORF20 [26], pORF42 [63] and pORF75a
[62] had previously been associated with MuHV-4 virions. Our
results suggest that these proteins are absent or extremely rare in
MuHV-4 virions. The absence of pORF75a was quite surprising
as its two homologues, pORF75c and pORF75b, were among the
most abundant proteins of MuHV-4 virions (on the basis of the
emPAI values). This therefore suggests that these proteins have
diverged to acquire new functions as proposed by Gaspar et al.
who observed that these proteins do not substitute functionally.
As observed in our analysis of BoHV-4 virions [36], the most
abundant MuHV-4 virion protein is encoded by ORF52 (Table 1).
ORF52 is conserved in gammaherpesvirinae and encodes a small
protein of ,20 kDa. In MuHV-4, ORF52 is essential for
tegumentation and secondary envelopment [26,63–65]. pORF52
seems to function as a dimer and the N-terminal a-helix is likely
involved in interactions with other virion components [66] such as
pORF33, pORF75, gM and gN in KSHV [67] and pORF42 in
MuHV-4 [63]. Even if pORF52 is a very abundant component of
MuHV-4 virion [64], its abundance in MuHV-4 could be
overestimated by the emPAI value. Indeed, emPAI calculation
integrates an intrinsic property of a protein which is the number of
peptides that will be generated through trypsin digestion.
However, the nature of the tryptic peptides and in particular
their capacity to get ionized in the mass spectrometer ion source is
not taken into account. pORF52 is a highly basic protein (pI
around 10) and its tryptic peptides could be more efficiently
ionized. These peptides could therefore appear as more abundant
Figure 5. Growth of MuHV-4 on Annexin A2 deficient mouse
embryonic fibroblasts. MEF cells from WT and Annexin A2-null mice
were infected with BAC+ MuHV-4 virions at a MOI of 0.01 for multi-step
assay as described in the Materials and Methods. Supernatants of
infected cultures or infected cells were harvested at successive intervals
and the amount of infectious virus determined by plaque assay on BHK-
21 cells. Plaques were visualized by fluorescent detection of eGFP. The
data presented are the average 6 SEMs for triplicate measurements.
The data were analyzed by 2way ANOVA and Bonferroni posttests.
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during mass spectrometry analysis. EmPAI has therefore to be
considered as an estimation of the abundance. Within a sample,
the relative proportions have to be mainly used to classify proteins
based on their abundance.
Based on emPAI analysis MuHV-4 pORF52 appears even
tenfold more abundant in virion than BoHV-4 pORF52.
However, mass spectrometry relies on on the flight selection by
the instrument of most abundant peptides to be fragmented and
identified. This selection can thus be biased by numerous
experimental condition factors such as the efficiency of protein
extraction or the method used for their separation. Therefore,
comparison of quantitative data concerning different proteins in
different biological matrices (BoHV-4 pORF52 and MuHV-4
pORF52) has to be considered cautiously and can be subject to
numerous experimental bias. The main conclusion that can
therefore be drawn from the analysis of pORF52 abundance in
MuHV-4 and BoHV-4 [36] virion analyses is that pORF52 is the
most abundant protein in virions of both species.
Finally, among these potential tegument proteins, 11 were
copurified with capsids (Table 2). The two proteins that were not
detected after removal of envelopes are pORF38 and pORF55.
This could be linked to their low abundance as only a few peptides
corresponding to these proteins were detected in entire virion
samples. However, pORF38 was also not detected in a similar
BoHV-4 capsid-tegument preparation [36]. This could be
explained by the association of pORF38 with some envelope
glycoproteins, as observed for its HSV-1 homologue pUL11 [68].
Envelope Proteins
The approach used in this study allowed the detection of 9
MuHV-4 envelope proteins encoded by ORFs 4, 8, 22, 27, 28, 39,
47, 51 and 58. These proteins were categorized as such based on
the extensive literature about them, on the presence of at least one
predicted transmembrane domain (excepted for gL encoded by
ORF47) and on their disappearance after removal of virus
envelope (Tables 1 and 2). Comparison of the relative abundance
of these proteins suggests that pORF4 (gp70), pORF8 (gB),
pORF22 (gH), pORF27 (gp48), pORF28 and pORF39 (gM) have
comparable abundance as their relative emPAI values (in
comparison with pORF25, the major capsid protein) range from
19 to 46%. In contrast, the relative abundance of pORF47 (gL)
was lower. As observed in other viruses, MuHV-4 gL associates
with gH to form a heterodimer that plays a central role in virus
binding [18] and in membrane fusion [69]. Our previous results
suggested that gH exists in two distinct forms at the surface of
MuHV-4 virions, either in association or not with gL [69]. This
fact could explain the difference of abundance between the two
proteins that we observed in this study. The relative abundance of
pORF51 (gp150) and pORF58 was also very low. In the case of
gp150, this apparent low abundance could be due to the high
degree of glycosylation of this protein as proposed for the
homologous BoHV-4 gp180 [36]. Concerning pORF58, this
could be linked to the low penetration of the protein in the
electrophoresis gel (Fig. 4) or to the formation of protein
aggregates as described above. Most of the detected envelope
proteins appeared to be glycosylated (Fig. 4).
Similar to what we observed with BoHV-4 [36], we did not
detect any peptide corresponding to gN which is encoded by
ORF53 (Table S2). gN and gM form a complex in herpesviruses
[39,70] and gN is needed for the proper processing of gM. gN
could dissociate from gM in mature virions as suggested for
HCMV [35]. However, it is not the case here as gN was readily
detected by western blotting on MuHV-4 virions even after
proteinase K treatment (Fig. 2). The absence of gN in our analysis
is therefore likely due to a detection failure by our mass
spectrometry approach. Similarly to what was observed for KSHV
and RRV, the viral G-protein coupled receptor encoded by
ORF74 has not been found in MuHV-4 virions.
Finally, the protein encoded by the M3 gene was found in all
our analyses of complete virions (n.10) even after proteinase K
treatment but not after deglycosylation (Table 1). M3 encodes a
MuHV-4 specific secreted 44 kDa which is highly expressed
during lytic infection [71]. This protein has a broad chemokine-
binding activity [72,73] and could prevent the migration of CD8+
T cells into sites where immunogenic latency antigens are
expressed. In accord with this suggestion, M3 disruption resulted
in reduced amplification of latently infected B cells [74,75].
However, the effect on lytic replication was less clear [75,76]. Our
results suggest that M3 could be associated with the surface of
MuHV-4 virions. Interestingly, glycoproteins G of alphaherpes-
viruses are chemokine-binding proteins that are present on the
viral particle and on the plasma membrane of infected cells
[77,78]. Although gGs are virulence factors [79], the mechanisms
beneath this phenotype remain unclear. Some reports highlighted
a role in virus entry [80,81]. MuHV-4 M3 disruption did not lead
to an apparent binding deficit in the cell-types that have been
tested so far. In the future, binding of M3-deficient virions to a
range of cell types will have to be tested.
Host Proteins Associated with MuHV-4 Extracellular
Virions
Host proteins are frequently associated with the structure of
virions from various families [82,83]. Despite some exceptions
[23], the functions of these proteins in virus biology are poorly
characterized. Host proteins have also been found in most of the
analyses of herpesvirus virion composition [24–36]. In our analysis
of MuHV-4 virions, we found 31 cellular proteins that were
detected in at least two of the three replicates (Table 3). Only 11 of
these proteins were still detected after proteinase K-treatment
(Table 3) and their relative abundances were quite low. Our results
suggest therefore that cellular proteins are minor components of
MuHV-4 virions. However, several of these proteins are small
GTPases (Rab-1A, Rab-6A, Rab-14) or proteins linked to
membrane organization and trafficking (VAMP3, Annexin A2)
that could reveal the egress pathway used by MuHV-4.
Interestingly, Annexin A2 was also proposed as a constituent of
several other herpesviruses (including KSHV, BoHV-4, AlHV-1,
HSV-1, PRV and HCMV) as well as influenza [84], HIV-1 [85],
papillomavirus [86] and Hepatitis C [87]. Annexin A2 is a 36 kDa
Ca2+-regulated phospholipid binding protein which exists both
free in the cytoplasm and associated with plasma membrane
surfaces. Annexins can function as organizers of membrane
domains and membrane recruitment platforms for proteins with
which they interact [88]. The role of Annexin A2 in herpesvirus
infection has mainly been studied with HCMV. Thus, Annexin A2
has been shown to associate with HCMV virions [89,90] through
specific interaction with gB [91,92]. Although this association is
well established, its functional importance is still subject to
controversies. Some studies showed that virion incorporated
Annexin A2 could accelerate fusion of membranes during entry
[93] in accordance with the observation that some Annexin A2
specific antibodies could inhibit HCMV infection [94]. In contrast,
other studies showed that Annexin A2 has no effect on HCMV
entry into fibroblasts [95]. Our results similarly showed that
despite being incorporated in MuHV-4 virions, Annexin A2 does
not influence growth of this virus in mouse embryonic fibroblasts
(Fig. 5). In the future, these results will have to be confirmed in
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other cell types as the effect of Annexin A2 on MuHV-4 biology
could be cell-specific as recently observed for HIV-1 [96].
In summary, we extended our comprehension of the compo-
sition of MuHV-4 virions in particular and of rhadinoviruses
virions in general. We identified 31 viral proteins as constituents of
MuHV-4 virions. Among these proteins, 30 were resistant to
proteinase-K treatment. Based on the literature, it appears that
this composition is very similar to those of BoHV-4 [36] and of
RRV virions [32]. This therefore allowed us to draw a schematic
MuHV-4 particle (Fig. 6) which is likely representative of the
general architecture of rhadinoviruses. Moreover, we identified 31
cellular proteins as potential structural components of MuHV-4
virions. However these proteins were not abundant and one of
them, Annexin A2, which has been detected in many herpesvi-
ruses, was non-essential to viral growth in vitro. In the future, these
results could improve our knowledge about different steps of the
biology of gammaherpesviruses.
Supporting Information
Figure S1 Analysis of peptides identified in the different
expression products of MuHV-4 ORF17-17.5 locus. The
predicted product of expression of ORF17 and ORF17.5 and their
respective cleavage products are represented by rectangles. Black
bars indicate the tryptic fragments identified by mass spectrom-
etry. Open triangles indicate protease cleavage sites.
(TIF)
Figure S2 Deglycosylation of MuHV-4 virions. Purified
MuHV-4 virions were either left untreated (/) or deglycosylated
(N2/O-) as indicated in the Materials and Methods. The samples
were then immunoblotted with mAbs 3F7 (anti-gN), 58-16D2
(anti-gp70), MG-4D11 (anti-gB C-terminal end), MG-2C10 (anti-
gB N-terminal end) or with rabbit polyserum raised against
MuHV-4 virions.
(TIF)
Figure S3 Prediction of N-glycosylation sites for the
different MuHV-4 protein sequences detected by our
approach using the NetNglyc 1.0 and NetOglyc 3.1
Figure 6. Schematic representation of the protein composition of mature extracellular MuHV-4 virions. Capsid proteins are represented
as hexagons, tegument proteins as circles, envelope proteins as triangles. As the location of the M3 protein is unknown, it is represented as a putative
structural protein (square). The predicted protein mass is directly proportional to their surface. The mean relative abundance (emPAI) determined by
the different analyses of complete virions is indicated in color intensity (see scale).
doi:10.1371/journal.pone.0083842.g006
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algorithms. The red lines indicate significative threshold.
Vertical blue lines indicate potential glycosylation sites.
(TIF)
Table S1 Comparison of MuHV-4 proteins identified in
virions with other herpesviruses.
(PDF)
Table S2 Comparison of MuHV-4 proteins non-identi-
fied in virions with observations in other herpesviruses.
(PDF)
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